JP6867304B2 - 血清による創傷治療システム - Google Patents
血清による創傷治療システム Download PDFInfo
- Publication number
- JP6867304B2 JP6867304B2 JP2017559013A JP2017559013A JP6867304B2 JP 6867304 B2 JP6867304 B2 JP 6867304B2 JP 2017559013 A JP2017559013 A JP 2017559013A JP 2017559013 A JP2017559013 A JP 2017559013A JP 6867304 B2 JP6867304 B2 JP 6867304B2
- Authority
- JP
- Japan
- Prior art keywords
- capillary membrane
- wound
- capillary
- liquid
- membrane system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000002966 serum Anatomy 0.000 title claims description 44
- 230000029663 wound healing Effects 0.000 title claims description 30
- 210000001601 blood-air barrier Anatomy 0.000 claims description 257
- 206010052428 Wound Diseases 0.000 claims description 170
- 208000027418 Wounds and injury Diseases 0.000 claims description 170
- 239000007788 liquid Substances 0.000 claims description 80
- 210000004369 blood Anatomy 0.000 claims description 59
- 239000008280 blood Substances 0.000 claims description 59
- 239000012528 membrane Substances 0.000 claims description 47
- 239000012466 permeate Substances 0.000 claims description 36
- 238000011282 treatment Methods 0.000 claims description 22
- 238000009826 distribution Methods 0.000 claims description 21
- 239000012530 fluid Substances 0.000 claims description 18
- 239000000126 substance Substances 0.000 claims description 11
- 239000007787 solid Substances 0.000 claims description 9
- 238000004140 cleaning Methods 0.000 claims description 7
- 238000007599 discharging Methods 0.000 claims description 7
- 238000002347 injection Methods 0.000 claims description 4
- 239000007924 injection Substances 0.000 claims description 4
- 210000003850 cellular structure Anatomy 0.000 claims description 3
- 230000001112 coagulating effect Effects 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 239000000463 material Substances 0.000 description 22
- 229920000642 polymer Polymers 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 238000005259 measurement Methods 0.000 description 13
- 210000001736 capillary Anatomy 0.000 description 12
- 239000012510 hollow fiber Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- 239000011148 porous material Substances 0.000 description 9
- 239000007789 gas Substances 0.000 description 8
- 229920001296 polysiloxane Polymers 0.000 description 8
- -1 media Substances 0.000 description 7
- 229920002678 cellulose Polymers 0.000 description 6
- 235000010980 cellulose Nutrition 0.000 description 6
- 210000000416 exudates and transudate Anatomy 0.000 description 6
- 238000009940 knitting Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 230000005484 gravity Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000010412 perfusion Effects 0.000 description 5
- 230000035699 permeability Effects 0.000 description 5
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 229920000728 polyester Polymers 0.000 description 4
- 150000003457 sulfones Chemical class 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 238000003466 welding Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000023555 blood coagulation Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- 229920005615 natural polymer Polymers 0.000 description 3
- 229920000620 organic polymer Polymers 0.000 description 3
- 229920005749 polyurethane resin Polymers 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 229920001059 synthetic polymer Polymers 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 239000004695 Polyether sulfone Substances 0.000 description 2
- 206010072170 Skin wound Diseases 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 239000003114 blood coagulation factor Substances 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000003822 epoxy resin Substances 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 229920002492 poly(sulfone) Polymers 0.000 description 2
- 229920002239 polyacrylonitrile Polymers 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000647 polyepoxide Polymers 0.000 description 2
- 229920006393 polyether sulfone Polymers 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940019700 blood coagulation factors Drugs 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229920003086 cellulose ether Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000004388 gamma ray sterilization Methods 0.000 description 1
- 238000004442 gravimetric analysis Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 239000004632 polycaprolactone Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 239000002210 silicon-based material Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/05—Bandages or dressings; Absorbent pads specially adapted for use with sub-pressure or over-pressure therapy, wound drainage or wound irrigation, e.g. for use with negative-pressure wound therapy [NPWT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/02—Blood transfusion apparatus
- A61M1/0209—Multiple bag systems for separating or storing blood components
- A61M1/0218—Multiple bag systems for separating or storing blood components with filters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/02—Blood transfusion apparatus
- A61M1/0281—Apparatus for treatment of blood or blood constituents prior to transfusion, e.g. washing, filtering or thawing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/147—Microfiltration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/0017—Wound bandages possibility of applying fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0413—Blood
- A61M2202/0415—Plasma
- A61M2202/0423—Serum; Human serous fluid, i.e. plasma without fibrinogen
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Water Supply & Treatment (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Anesthesiology (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- External Artificial Organs (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Materials Engineering (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Dispersion Chemistry (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15167089.0A EP3092987A1 (de) | 2015-05-11 | 2015-05-11 | System zur wundbehandlung mit serum |
| EP15167089.0 | 2015-05-11 | ||
| PCT/IB2016/052660 WO2016181301A1 (de) | 2015-05-11 | 2016-05-10 | System zur wundbehandlung mit serum |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018527035A JP2018527035A (ja) | 2018-09-20 |
| JP2018527035A5 JP2018527035A5 (enExample) | 2019-06-13 |
| JP6867304B2 true JP6867304B2 (ja) | 2021-04-28 |
Family
ID=53174851
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017559013A Expired - Fee Related JP6867304B2 (ja) | 2015-05-11 | 2016-05-10 | 血清による創傷治療システム |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US10617569B2 (enExample) |
| EP (2) | EP3092987A1 (enExample) |
| JP (1) | JP6867304B2 (enExample) |
| CN (1) | CN107580483B (enExample) |
| WO (1) | WO2016181301A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0808376D0 (en) | 2008-05-08 | 2008-06-18 | Bristol Myers Squibb Co | Wound dressing |
| GB0817796D0 (en) | 2008-09-29 | 2008-11-05 | Convatec Inc | wound dressing |
| GB201020236D0 (en) | 2010-11-30 | 2011-01-12 | Convatec Technologies Inc | A composition for detecting biofilms on viable tissues |
| CN103347562B (zh) | 2010-12-08 | 2016-08-10 | 康沃特克科技公司 | 伤口分泌液系统附件 |
| DK2648795T3 (da) | 2010-12-08 | 2023-03-27 | Convatec Technologies Inc | System til fjernelse af eksudater fra en sårposition |
| CA2819475C (en) | 2010-12-08 | 2019-02-12 | Convatec Technologies Inc. | Integrated system for assessing wound exudates |
| GB201115182D0 (en) | 2011-09-02 | 2011-10-19 | Trio Healthcare Ltd | Skin contact material |
| GB2497406A (en) | 2011-11-29 | 2013-06-12 | Webtec Converting Llc | Dressing with a perforated binder layer |
| MX2015007771A (es) | 2012-12-20 | 2015-09-04 | Convatec Technologies Inc | Procesamiento de fibras celulosicas quimicamente modificadas. |
| GB2543544A (en) | 2015-10-21 | 2017-04-26 | Brightwake Ltd | Wound dressing |
| JP7183146B2 (ja) | 2016-03-30 | 2022-12-05 | コンバテック・テクノロジーズ・インコーポレイテッド | 創傷における微生物感染の検出 |
| JP2019513238A (ja) | 2016-03-30 | 2019-05-23 | クオリザイム・ダイアグノスティクス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・コムパニー・コマンディットゲゼルシャフトQualizyme Diagnostics Gmbh And Co. Kg | 創傷における微生物感染の検出 |
| GB201608099D0 (en) | 2016-05-09 | 2016-06-22 | Convatec Technologies Inc | Negative pressure wound dressing |
| BR112019000284A2 (pt) | 2016-07-08 | 2019-04-16 | Convatec Technologies Inc. | aparelho de coleta de fluido |
| DK3481360T3 (da) | 2016-07-08 | 2022-03-28 | Convatec Technologies Inc | Fluidstrømningsmåling |
| KR20190026858A (ko) | 2016-07-08 | 2019-03-13 | 컨바텍 테크놀러지스 인크 | 가요성 부압 시스템 |
| WO2018156730A1 (en) | 2017-02-22 | 2018-08-30 | Cornell University | Mechanical vacuum dressing for mechanically managing, protecting and suctioning small incisional wounds |
| EP3710074B1 (en) | 2017-11-16 | 2024-03-20 | ConvaTec Limited | Fluid collection apparatus |
| WO2019113275A1 (en) | 2017-12-06 | 2019-06-13 | Cornell University | Manually-operated negative pressure wound therapy (npwt) bandage with improved pump efficiency, automatic pressure indicator and automatic pressure limiter |
| EP3962544B1 (en) | 2019-06-03 | 2023-11-08 | Convatec Limited | Methods and devices to disrupt and contain pathogens |
| US11331221B2 (en) | 2019-12-27 | 2022-05-17 | Convatec Limited | Negative pressure wound dressing |
| US11771819B2 (en) | 2019-12-27 | 2023-10-03 | Convatec Limited | Low profile filter devices suitable for use in negative pressure wound therapy systems |
| DE102020207084A1 (de) * | 2020-06-05 | 2021-12-09 | B. Braun Melsungen Aktiengesellschaft | Infusionsfilter |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2833493C2 (de) | 1978-07-31 | 1989-10-12 | Akzo Gmbh, 5600 Wuppertal | Hohlfäden |
| DE3302383C2 (de) | 1983-01-25 | 1985-08-29 | Michael J. 8000 München Lysaght | Verfahren und Vorrichtung zur Gewinnung von Blutplasma |
| DE3617724A1 (de) | 1986-05-27 | 1987-12-03 | Akzo Gmbh | Verfahren zur bestimmung des blaspunktes bzw. der groessten pore von membranen oder filterwerkstoffen |
| ES2041668T3 (es) | 1986-10-29 | 1993-12-01 | Asahi Medical Co., Ltd. | Unidad de recogida de componentes de la sangre. |
| CA1323271C (en) | 1987-07-11 | 1993-10-19 | Takanori Anazawa | Membrane-type artificial lung and method of using it |
| DE3829752A1 (de) | 1988-09-01 | 1990-03-22 | Akzo Gmbh | Integrale asymmetrische polyaethersulfonmembran, verfahren zur herstellung und verwendung zur ultrafiltration und mikrofiltration |
| DE3839567A1 (de) | 1988-11-24 | 1990-06-07 | Akzo Gmbh | Hohlfadenmodul zum abtrennen von gas |
| DE4004797A1 (de) | 1990-02-16 | 1991-08-22 | Akzo Gmbh | Gewebtes hohlfadenband |
| DE4308850A1 (de) | 1993-03-19 | 1994-09-22 | Akzo Nv | Hohlfadenmatte |
| DE4421871C2 (de) | 1994-06-23 | 1997-06-19 | Seitz Filter Werke | Mehrschichtige Mikrofiltrationsmembran mit integrierter Vorfilterschicht und Verfahren zu ihrer Herstellung |
| DE29516471U1 (de) | 1995-10-17 | 1996-01-25 | Caditec Medical & Technic GmbH, 67655 Kaiserslautern | Bluttrennvorrichtung |
| WO1997022405A1 (en) | 1995-12-18 | 1997-06-26 | Asahi Kasei Kogyo Kabushiki Kaisha | Hollow fiber type filtration membrane |
| WO2000043114A1 (de) | 1999-01-21 | 2000-07-27 | Membrana Gmbh | Integral asymmetrische polyolefinmembran |
| ATE321579T1 (de) | 1999-04-20 | 2006-04-15 | Heim Medizintechnik Gmbh | Vorrichtung zum auftrennen von blut in einzelne und/oder gruppen seiner bestandteile |
| CN100342927C (zh) | 1999-11-01 | 2007-10-17 | 旭化成医疗株式会社 | 用于选择性去除白血球的过滤器 |
| US6645388B2 (en) | 1999-12-22 | 2003-11-11 | Kimberly-Clark Corporation | Leukocyte depletion filter media, filter produced therefrom, method of making same and method of using same |
| DE20014311U1 (de) * | 2000-08-15 | 2001-02-15 | HEIM Medizintechnik GmbH, 45966 Gladbeck | Filteranordnung zum Auftrennen von Blut in Plasma und zelluläre Bestandteile |
| US6610002B2 (en) * | 2001-04-09 | 2003-08-26 | Medtronic, Inc. | Method for handling blood sample to ensure blood components are isolated |
| US20050107868A1 (en) * | 2002-03-28 | 2005-05-19 | JAPAN as represented by President of NATIONAL & CARDIOVASCULAR CENTER | Scaffold for tissue engineering, artificial blood vessel, cuff, and biological implant covering member |
| WO2003094937A1 (en) * | 2002-05-09 | 2003-11-20 | Medigenes | A pharmaceutical composition for treatment of wounds containing blood plasma or serum |
| EP1625861A4 (en) * | 2003-05-21 | 2012-04-11 | Jms Co Ltd | CONTAINER FOR SERUM PRODUCTION AND REGENERATIVE MEDICINE METHOD USING SAID CONTAINER |
| DE10326747B4 (de) | 2003-06-13 | 2006-11-02 | Gerlach, Jörg, Dr.med. | Perfusionseinheit und Perfusionsstation zur Hautwundbehandlung sowie dessen Verwendung |
| GB0518826D0 (en) * | 2005-09-15 | 2005-10-26 | Smith & Nephew | Apparatus with actives from tissue - exudialysis |
| GB0325120D0 (en) * | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus with actives |
| US8529548B2 (en) | 2004-04-27 | 2013-09-10 | Smith & Nephew Plc | Wound treatment apparatus and method |
| DE102005026804B3 (de) | 2005-06-09 | 2007-02-22 | Membrana Gmbh | Mikrofiltrationsmembran mit verbessertem Filtrationsverhalten |
| DE102005035528A1 (de) | 2005-07-26 | 2007-02-01 | Heim Medizintechnik Gmbh | Dampfsterilisierbare Bluttrennvorrichtung |
| EP2024068B1 (de) | 2006-05-06 | 2012-01-18 | Membrana GmbH | Ultrafiltrationsmembran |
| DE102006042732B3 (de) * | 2006-09-12 | 2008-04-10 | Gerlach, Jörg, Dr.med. | Künstliches arterio-venöses permeables Hohlfaserkapillarsystem |
| US8529958B2 (en) * | 2006-10-17 | 2013-09-10 | Carmell Therapeutics Corporation | Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom |
| JP5577569B2 (ja) * | 2007-03-07 | 2014-08-27 | 株式会社ジェイ・エム・エス | 血清調製方法 |
| JP2008232876A (ja) * | 2007-03-22 | 2008-10-02 | Sekisui Chem Co Ltd | 血球停止膜、血液分離フィルタ、血液分離装置及び検体採取容器 |
| JP5266929B2 (ja) | 2007-07-30 | 2013-08-21 | 株式会社ジェイ・エム・エス | 血液成分分離収容装置 |
| WO2009134967A2 (en) | 2008-04-30 | 2009-11-05 | Kci Licensing, Inc. | Use of nucleic acids with reduced pressure therapy |
| JP5593707B2 (ja) * | 2009-02-04 | 2014-09-24 | 株式会社ジェイ・エム・エス | 液性成分採取装置 |
| DE102009022793A1 (de) | 2009-05-27 | 2010-12-02 | Justus-Liebig-Universität Giessen | Vorrichtung und Verfahren zur Herstellung von Blutprodukten |
| EP2264453B1 (en) * | 2009-06-17 | 2013-04-03 | Leukocare Ag | Method for filtering blood |
| GB201004072D0 (en) * | 2010-03-11 | 2010-04-28 | Turzi Antoine | Process, tube and device for the preparation of wound healant composition |
| DE102010030238A1 (de) | 2010-06-17 | 2011-12-22 | Lmb Lab Med Blutbank Technologie Gmbh | Durchflussfilter zum Separieren von Blut in Plasma und zelluläre Bestandteile |
| US9050211B2 (en) * | 2011-02-22 | 2015-06-09 | Oleg Siniaguine | Self-adaptive and optionally also otherwise adaptable wound dressing |
| BR112013025989B1 (pt) | 2011-04-13 | 2021-02-02 | 3M Innovative Properties Company | membrana de filtração macroporosa e equipamento de infusão para a administração de soluções de infusão |
| US20130046223A1 (en) * | 2011-08-15 | 2013-02-21 | Stephen Schrammel | Long Term Wound Dressing |
| SI2956150T1 (sl) * | 2013-02-12 | 2022-02-28 | Lacerta Technologies Inc. | Serumska frakcija fibrina obogatenega s trombociti |
| DE102013010735A1 (de) * | 2013-06-27 | 2015-01-15 | Mann + Hummel Gmbh | Keramisches Vollbluthohlfasermembranfiltermedium und Verwendung davon zum Abtrennen von Blutplasma/-serum von Vollblut |
| US9649941B2 (en) | 2013-07-11 | 2017-05-16 | Ford Global Technologies, Llc | Boost converter deadtime compensation |
| EP3038635A4 (en) * | 2013-08-28 | 2017-04-05 | Cytonics Corporation | Systems, compositions, and methods for transplantation and treating conditions |
| US10286127B2 (en) | 2013-11-13 | 2019-05-14 | 3M Innovative Properties Company | Pouch-shaped wound dressing system |
| WO2015071280A1 (de) | 2013-11-13 | 2015-05-21 | Membrana Gmbh | Wundversorgungssystem mit einer matte aus kapillarmembranen |
-
2015
- 2015-05-11 EP EP15167089.0A patent/EP3092987A1/de not_active Withdrawn
-
2016
- 2016-05-10 WO PCT/IB2016/052660 patent/WO2016181301A1/de not_active Ceased
- 2016-05-10 CN CN201680027186.7A patent/CN107580483B/zh not_active Expired - Fee Related
- 2016-05-10 EP EP16724719.6A patent/EP3294244B1/de active Active
- 2016-05-10 JP JP2017559013A patent/JP6867304B2/ja not_active Expired - Fee Related
- 2016-05-10 US US15/571,407 patent/US10617569B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP3294244B1 (de) | 2019-06-26 |
| JP2018527035A (ja) | 2018-09-20 |
| EP3294244A1 (de) | 2018-03-21 |
| CN107580483A (zh) | 2018-01-12 |
| US10617569B2 (en) | 2020-04-14 |
| CN107580483B (zh) | 2021-05-28 |
| WO2016181301A1 (de) | 2016-11-17 |
| US20180303676A1 (en) | 2018-10-25 |
| EP3092987A1 (de) | 2016-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6867304B2 (ja) | 血清による創傷治療システム | |
| JP6525997B2 (ja) | 袋型創傷被覆材システム | |
| JP2018519013A (ja) | 創傷管理システム | |
| JP5390625B2 (ja) | 減圧式腹部治療システムおよび方法 | |
| CN102015008B (zh) | 用于真空伤口治疗的真空端口 | |
| US20040034317A1 (en) | Method and apparatus for therapeutic apheresis | |
| CN102858384A (zh) | 用于密封切口的系统和方法 | |
| KR20090121372A (ko) | 세포 팽창 장치에 사용하기 위한 일회용 배관 세트 및 무균 샘플링 방법 | |
| JP2018518241A (ja) | 血清を取得するためのシステム及び方法 | |
| JP6453879B2 (ja) | キャピラリー膜のマットを有する創傷ケアシステム | |
| EP3372257A1 (en) | Negative pressure wound therapy assembly | |
| JP2003507149A (ja) | 循環流体を生物学的に処理するための神経膠星状細胞装置 | |
| US11911549B2 (en) | Plasmapheresis device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190510 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190510 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200519 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20200818 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201111 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210309 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210408 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6867304 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| LAPS | Cancellation because of no payment of annual fees |